Submitted by politico6147 in business
The drugmaker will discontinue development and marketing for Aduhelm, a landmark Alzheimer's disease treatment.
Submitted by politico6147 in business
The drugmaker will discontinue development and marketing for Aduhelm, a landmark Alzheimer's disease treatment.